Literature DB >> 21338628

Molecular determinants and feedback circuits regulating type 2 CRH receptor signal integration.

Danijela Markovic1, Anu Punn, Hendrik Lehnert, Dimitris K Grammatopoulos.   

Abstract

In most target tissues, the adenylyl cyclase/cAMP/PKA, the extracellular signal regulated kinase and the protein kinase B/Akt are the main pathways employed by the type 2 corticotropin-releasing hormone receptor to mediate the biological actions of urocortins (Ucns) and CRH. To decipher the molecular determinants of CRH-R2 signaling, we studied the signaling pathways in HEK293 cells overexpressing recombinant human CRH-R2β receptors. Use of specific kinase inhibitors showed that the CRH-R2β cognate agonist, Ucn 2, activated extracellular signal regulated kinase in a phosphoinositide 3-kinase and cyclic adenosine monophosphate/PKA-dependent manner with contribution from Epac activation. Ucn 2 also induced PKA-dependent association between AKAP250 and CRH-R2β that appeared to be necessary for extracellular signal regulated kinase activation. PKB/Akt activation was also mediated via pertussis toxin-sensitive G-proteins and PI3-K activation but did not require cAMP/PKA, Epac or protein kinase C for optimal activation. Potential feedback mechanisms that target the CRH-R2β itself and modulate receptor trafficking and endocytosis were also investigated. Indeed, our results suggested that inhibition of either PKA or extracellular signal regulated kinase pathway accelerates CRH-R2β endocytosis. Furthermore, Ucn 2-activated extracellular signal regulated kinase appeared to target β-arrestin1 and modulate, through phosphorylation at Ser412, β-arrestin1 translocation to the plasma membrane and CRH-R2β internalization kinetics. Loss of this "negative feedback" mechanism through inhibition of the extracellular signal regulated kinase activity resulted in significant attenuation of Ucn 2-induced cAMP response, whereas Akt phosphorylation was not affected by altered receptor endocytosis. These findings reveal a complex interplay between the signaling molecules that allow "fine-tuning" of CRH-R2β functional responses and regulate signal integration. This article is part of a Special Issue entitled: 11th European Symposium on Calcium. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21338628     DOI: 10.1016/j.bbamcr.2011.02.005

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  9 in total

Review 1.  Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction.

Authors:  Dimitris K Grammatopoulos
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 2.  Endocrinology and the brain: corticotropin-releasing hormone signaling.

Authors:  Carolina Inda; Natalia G Armando; Paula A Dos Santos Claro; Susana Silberstein
Journal:  Endocr Connect       Date:  2017-07-14       Impact factor: 3.335

3.  Metabolic Association between Leptin and the Corticotropin Releasing Hormone.

Authors:  Sofia Gioldasi; Alexia Karvela; Andrea Paola Rojas-Gil; Maria Rodi; Anne-Lise de Lastic; Iason Thomas; Bessie E Spiliotis; Athanasia Mouzaki
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2019       Impact factor: 2.895

4.  Agonist bias and agonist-dependent antagonism at corticotrophin releasing factor receptors.

Authors:  Zoe Tasma; Peter Wills; Debbie L Hay; Christopher S Walker
Journal:  Pharmacol Res Perspect       Date:  2020-06

5.  CRF1 Receptor Signaling via the ERK1/2-MAP and Akt Kinase Cascades: Roles of Src, EGF Receptor, and PI3-Kinase Mechanisms.

Authors:  G Karina Parra-Mercado; Alma M Fuentes-Gonzalez; Judith Hernandez-Aranda; Monica Diaz-Coranguez; Frank M Dautzenberg; Kevin J Catt; Richard L Hauger; J Alberto Olivares-Reyes
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-12       Impact factor: 5.555

6.  Acute Corticotropin-Releasing Factor Receptor Type 2 Agonism Results in Sustained Symptom Improvement in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  Gerard Pereira; Hunter Gillies; Sanjay Chanda; Michael Corbett; Suzanne D Vernon; Tina Milani; Lucinda Bateman
Journal:  Front Syst Neurosci       Date:  2021-09-01

7.  Effects of corticotrophin releasing hormone (CRH) on cell viability and differentiation in the human BeWo choriocarcinoma cell line: a potential syncytialisation inducer distinct from cyclic adenosine monophosphate (cAMP).

Authors:  YuXia Chen; Megan Allars; Xin Pan; Kaushik Maiti; Giavanna Angeli; Roger Smith; Richard C Nicholson
Journal:  Reprod Biol Endocrinol       Date:  2013-04-15       Impact factor: 5.211

Review 8.  Role of EPAC in cAMP-Mediated Actions in Adrenocortical Cells.

Authors:  Aurélia E Lewis; Reidun Aesoy; Marit Bakke
Journal:  Front Endocrinol (Lausanne)       Date:  2016-06-13       Impact factor: 5.555

9.  Urocortin-1 Mediated Cardioprotection Involves XIAP and CD40-Ligand Recovery: Role of EPAC2 and ERK1/2.

Authors:  Eva Calderón-Sánchez; Ignacio Díaz; Antonio Ordóñez; Tarik Smani
Journal:  PLoS One       Date:  2016-02-03       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.